Skip to main content

Advertisement

SpringerLink
Log in

Prognostic importance of histomorphologic subclassification for epithelial thymic tumors

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: The prognostic importance of various clinical variables (age, sex, association with myasthenia gravis), staging according to Masaoka, histologic type according to the Marino/Kirchner/Müller-Hermelink (MKM-H) classification, and residual tumor category (R category) was evaluated in a retrospective analysis.

Methods: Eighty-two patients with epithelial thymic tumors (ETTs) treated in the period 1969–1993 were evaluated, and archived specimens were histologically reclassified according to the classification of MKM-H.

Results: Age, sex, and association with myasthenia gravis were of no prognostic importance. The R category is of significant prognostic importance, with 5- and 10-year survival rates of 93.6% and 87.3%, respectively, for R0 resections compared with 0% at 5 years for R1 and R2 resections (p<0.001). Staging (Masaoka) proved to be a prognostic factor (5-/10-year survival: stage I, 100%/90.9%; II, 95%/88.2%; III, 55.9%/46.6%; and IV, 10.8%/10.8%; p<0.001). Histologic typing according to MKM-H is also of significant prognostic importance (5/10 year survival: thymomas: medullary, 100%/100%; mixed, 100%/100%, predominantly cortical, 68.6%/68.6%; cortical, 65.8%/65.8%; thymic carcinomas: well-differentiated type, 62.3%/44.5%; thymic carcinomas other than well-differentiated type, 33.6%/26.9%; p<0.001). Multivariate analysis demonstrated that staging (p<0.001), R category (p<0.026), and MKM-H classification (p<0.028) have an independent impact on survival.

Conclusions: Staging (Masaoka), R category, and histologic classification (MKM-H) are important independent prognostic factors for patients with epithelial thymic tumors. Complete (R0) surgical resections should be the ultimate goal in the clinical management of patients with epithelial thymic tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wilkins EW, Edmunds LH, Castleman B. Cases of thymoma at the Massachusetts General Hospital.J Thorac Cardiovasc Surg 1966;52:322–30.

    PubMed  Google Scholar 

  2. Rosai J, Levine GD. Tumors of the thymus. In:Atlas of tumor pathology. 2nd series, fascicle 13. Washington, DC: Armed Forces Institute of Pathology, 1976:34–182.

    Google Scholar 

  3. Snover DC, Levine GD, Rosai J. Thymic carcinoma: five distinct histological variants.Am J Surg Pathol 1982;6:451–70.

    CAS  PubMed  Google Scholar 

  4. Lattes R. Thymoma and other tumors of the thymus. An analysis of 107 cases.Cancer 1962;15:1224–60.

    Google Scholar 

  5. Salyer WR, Eggleston JC. Thymoma: a clinical and pathological study of 65 cases.Cancer 1976;37:229–49.

    CAS  PubMed  Google Scholar 

  6. Bernatz PE, Harrison EG, Clagett OT. Thymoma: a clinico-pathologic study.J Thorac Cardiovasc Surg 1961;42:424–44.

    CAS  Google Scholar 

  7. Maggi G, Casadio C, Cavallo A, Cianci R, Molonatti M, Ruffini E. Thymoma: results of 241 operated cases.Ann Thorac Surg 1991;51:152–6.

    CAS  PubMed  Google Scholar 

  8. Marino M, Müller-Hermelink HK. Thymoma and thymic carcinoma—relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus.Virchows Arch [A] 1985;407:119–49.

    CAS  Google Scholar 

  9. Kirchner T, Müller-Hermelink HK. New approaches to the diagnosis of thymic epithelial tumors.Prog Surg Pathol 1989;10:167–89.

    Google Scholar 

  10. Kirchner T, Schalke B, Buchwald J, Ritter M, Marx A, Müller-Hermelink HK. Well-differentiated thymic carcinoma: an organotypical low-grade carcinoma with relationship to cortical thymoma.Am J Surg Pathol 1992;16:1153–69.

    CAS  PubMed  Google Scholar 

  11. Pescarmona EO, Rendina EA, Venuta F, Ricci C, Ruco LP, Baroni CD. The prognostic importance of thymoma histologic subtyping.Am J Clin Pathol 1990;93:190–5.

    CAS  PubMed  Google Scholar 

  12. Pescarmona EO, Rendina EA, Venuta F, et al. Analysis of prognostic factors and clinicopathological staging of thymoma.Ann Thorac Surg 1990;50:534–8.

    CAS  PubMed  Google Scholar 

  13. Ricci C, Rendina EA, Pescarmona EO, et al. Correlations between histological type, clinical behaviour, and prognosis in thymoma.Thorax 1989;44:455–60.

    CAS  PubMed  Google Scholar 

  14. Quintanilla-Martinez L, Wilkins EW, Choi N, Efrid J, Hug E, Harris NL. Thymoma: histologic subclassification is an independent prognostic factor.Cancer 1994;74:606–17.

    CAS  PubMed  Google Scholar 

  15. Quintanilla-Martinez L, Wilkins EW, Ferry JA, Harris NL. Thymoma: morphologic subclassification correlates with Invasiveness and immunohistologic features.Hum Pathol 1993;24:958–69.

    Article  CAS  PubMed  Google Scholar 

  16. Kornstein MJ, Curran WJ, Turrisi AT III, Brooks JJ. Cortical versus medullary thymomas: a useful morphologic distinction?Hum Pathol 1988;19:1335–9.

    CAS  PubMed  Google Scholar 

  17. Shimosato YS. Controversies surrounding the subclassification of thymoma.Cancer 1994;74:542–54.

    CAS  PubMed  Google Scholar 

  18. Bergh NP, Gatzinsky P, Larsson S, Lundin P, Ridell B. Tumors of the thymus and thymic region. I. Clinicopathological studies on thymomas.Ann Thorac Surg 1978;25:91–8.

    CAS  PubMed  Google Scholar 

  19. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study with special references to their clinical stages.Cancer 1981;48:2485–92.

    CAS  PubMed  Google Scholar 

  20. Etienne T, Delaval PJ, Spiliopoulos A, Megevand R. Thymoma: prognostic factors.Eur J Cardiothorac Surg 1993;7:449–52.

    Article  CAS  PubMed  Google Scholar 

  21. Gamondes JP, Balawi A, Greenland P, et al. Seventeen years of surgical treatment of thymoma: factors influencing survival.Eur J Cardiothorac Surg 1991;5:124–31.

    Article  CAS  PubMed  Google Scholar 

  22. Verley JM, Hollmann KH. Thymoma: a comparative study of clinical stages, histologic features and survival in 200 cases.Cancer 1985;55:1074–86.

    CAS  PubMed  Google Scholar 

  23. Wilkins EW, Grillo HC, Scannell JG, Moncure AC, Mathisen DJ. Role of staging in prognosis and management of thymoma.Ann Thorac Surg 1991;51:888–92.

    PubMed  Google Scholar 

  24. Hermanek P, Henson DE, Hutter RVP, Sobin LH, eds.UICC TNM supplement. Berlin: Springer-Verlag, 1993:9–14.

    Google Scholar 

  25. Nakahara K, Ohno K, Hahimoto J, et al. Thymoma: results with complete resection and adjuvant postoperative irradiation in 141 consecutive patients.J Thoracid Cadiovasc Surg 1988;95:1041–7.

    CAS  Google Scholar 

  26. Fuentes P, Leude E, Ruiz C, et al. Treatment of thymomas: a report of 67 cases.Eur J Cardiothorac Surg 1992;6:180–8.

    Article  CAS  PubMed  Google Scholar 

  27. Penn CRH, Hope-Stone HF. The role of radiotherapy in management of malignant thymoma.Br J Surg 1972;59:533–9.

    CAS  PubMed  Google Scholar 

  28. Urgesi A, Monetti U, Rossi G, Ricardi U, Casadio C. Role of radiation therapy in locally advanced thymoma.Radiother Oncol 1990;19:372–80.

    Article  Google Scholar 

  29. Arakawa A, Yasunaga T, Saitoh Y, et al. Radiation therapy of invasive thymoma.Int J Radiat Oncology Biol Phys 1990;18:529–34.

    CAS  Google Scholar 

  30. Kersh CR, Eisert DR, Hazra TA. Malignant thymoma: role of radiation therapy in management.Radiology 1985;156:207–9.

    CAS  PubMed  Google Scholar 

  31. Evans WK, Thompson DM, Simpson WJ, Fels R, Phillips MJ. Combination chemotherapy in invasive thymoma: role of COPP.Cancer 1980;46:1523–7.

    CAS  PubMed  Google Scholar 

  32. Fornasiero A, Daniele O, Ghiotto C, et al. Chemotherapy for invasive thymoma: a 13-year experience.Cancer 1991;68:30–3.

    CAS  PubMed  Google Scholar 

  33. Macchiarini P, Chella A, Ducci F, et al. Neoadjuvant chemotherapy, surgery and postoperative radiation therapy for invasive thymoma.Cancer 1991;68:706–13.

    CAS  PubMed  Google Scholar 

  34. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations.J Am Stat Assoc 1958;53:457–80.

    Google Scholar 

  35. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration.Cancer Chemother Rep 1966;50:163–70.

    CAS  PubMed  Google Scholar 

  36. Cox DR. Regression models and life tables (with discussion).R Stat Soc 1972;34:187–220.

    Google Scholar 

  37. Dixon WJ, Brown MB, Engelman L, Hill MA, Jennrich RI, eds.B.M.D.P. statistical software manual. Vol. 2. Berkeley, CA: University of California Press, 1988:689–742.

    Google Scholar 

  38. Wang L-S, Huang M-H, Lin T-S, Huang B-S, Chien K-Y. Malignant thymoma.Cancer 1992;70:443–50.

    CAS  PubMed  Google Scholar 

  39. Wick MR. Assessing the prognosis of thymomas.Ann Thorac Surg 1990;50:534–8.

    Google Scholar 

  40. Lewis JE, Wick MR, Scheithauer BW, Bernatz PE, Taylor WF. Thmoma: a clinicopathological review.Cancer 1987;60:2727–43.

    CAS  PubMed  Google Scholar 

  41. Fuentes P, Leude E, Ruiz C, et al. Treatment of thymomas.Eur J Cardiothorac Surg 1992;6:180–8.

    Article  CAS  PubMed  Google Scholar 

  42. Cohen DJ, Ronnigen LD, Graeber GM, et al. Management of patients with malignant thymoma.J Thorac Cardiovasc Surg 1984;87:301–7.

    CAS  PubMed  Google Scholar 

  43. Martini N, Kaiser LR. Clinical management of thymomas: the Memorial Sloan-Kettering Cancer Center experience. In:Thoracic surgery: frontiers and uncommon neoplasms. Vol. 5. St. Louis: CV Mosby, 1989:176–83.

    Google Scholar 

  44. Kuo T-T, Lo S-K. Thymoma: a study of the pathological classification of 71 cases with evaluation of the Muller-Hermelink System.Hum Pathol 1993;24:766–71.

    CAS  PubMed  Google Scholar 

  45. Kirschner PA. Reoperation for thymoma: report of 23 cases.Ann Thorac Surg 1990;49:550–5.

    CAS  PubMed  Google Scholar 

  46. Suster S, Rosai J. Thymic carcinoma: a clinicopathologic study of 60 cases.Cancer 1991;67:1025–32.

    CAS  PubMed  Google Scholar 

  47. Loehrer PJ, Rerez CA, Roth LM, Greco A, Livingston RB, Einhorn LH. Chemotherapy for advanced thymoma.Ann Intern Med 1990;113:520–4.

    PubMed  Google Scholar 

  48. Park HS, Shin DM, Lee LS, et al. Thymoma: a retrospective study of 87 cases.Cancer 1994;73:2491–8.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. From the Department of Surgery, The Technical University of Munich Medical Center, Munich, Germany

    Paul M. Schneider MD, Ulrich Fink MD & Elfriede Bollschweiler MD, PhD

  2. Department of the Thoracic Surgery Unit, The Technical University of Munich Medical Center, Munich, Germany

    Heinz W. Präuer MD

  3. the Department of Pathology, The Technical University of Munich Medical Center, Munich, Germany

    Christian Fellbaum MD

Authors
  1. Paul M. Schneider MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christian Fellbaum MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ulrich Fink MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Elfriede Bollschweiler MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Heinz W. Präuer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schneider, P.M., Fellbaum, C., Fink, U. et al. Prognostic importance of histomorphologic subclassification for epithelial thymic tumors. Annals of Surgical Oncology 4, 46–56 (1997). https://doi.org/10.1007/BF02316810

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02316810

Key Words

Search

Navigation